264 related articles for article (PubMed ID: 7841300)
1. Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution.
Steinmann C; Bögli C; Jungo M; Lämmle B; Heinemann G; Wermuth B; Redaelli R; Baudo F; Furlan M
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):463-71. PubMed ID: 7841300
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain.
Stucki B; Zenhäusern R; Biedermann B; Baudo F; Redaelli R; Lämmle B; Furlan M
Blood Coagul Fibrinolysis; 1999 Mar; 10(2):93-9. PubMed ID: 10192658
[TBL] [Abstract][Full Text] [Related]
4. A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo.
Margaglione M; Vecchione G; Santacroce R; D'Angelo F; Casetta B; Papa ML; Grandone E; Di Minno G
Thromb Haemost; 2001 Dec; 86(6):1483-8. PubMed ID: 11776317
[TBL] [Abstract][Full Text] [Related]
5. A new substitution, gamma 358 Ser-->Cys, in fibrinogen Milano VII causes defective fibrin polymerization.
Steinmann C; Bögli C; Jungo M; Lämmle B; Heinemann G; Wermuth B; Redaelli R; Baudo F; Furlan M
Blood; 1994 Sep; 84(6):1874-80. PubMed ID: 8080993
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen Geneva, a new case of A alpha 16 Arg----Cys dysfibrinogenaemia.
Furlan M; Bögli C; Hofer A; Bouvier CA; de Moerloose P
Blood Coagul Fibrinolysis; 1990 Jun; 1(2):139-43. PubMed ID: 2130925
[TBL] [Abstract][Full Text] [Related]
7. [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys].
Furlan M; Leupin L; Biasiutti FD; Lämmle B
Schweiz Med Wochenschr; 1991 Jul; 121(29):1068-71. PubMed ID: 1891701
[TBL] [Abstract][Full Text] [Related]
8. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B
Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).
Bögli C; Hofer A; Baudo F; Redaelli R; Furlan M
Haemostasis; 1992; 22(1):7-11. PubMed ID: 1521828
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization.
Lounes KC; Soria C; Valognes A; Turchini MF; Soria J; Koopman J
Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant.
Yoshida N; Imaoka S; Hirata H; Matsuda M; Asakura S
Thromb Haemost; 1992 Nov; 68(5):534-8. PubMed ID: 1455400
[TBL] [Abstract][Full Text] [Related]
13. Abnormal polymerization and normal binding of plasminogen and t-PA in three new dysfibrinogenaemias: Barcelona III and IV (gamma Arg 275-->His) and Villajoyosa (gamma Arg 275-->Cys).
Borrell M; Garí M; Coll I; Vallvé C; Tirado I; Soria JM; Sala N; Muñoz C; Oliver A; García A
Blood Coagul Fibrinolysis; 1995 May; 6(3):198-206. PubMed ID: 7654933
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.
Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
Okumura N; Furihata K; Terasawa F; Nakagoshi R; Ueno I; Katsuyama T
Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen New Britain: characterization of an A alpha Arg 16-->His variant human fibrinogen.
Webb CD; Hantgan RR; Byeff PD; Owen J
Blood Coagul Fibrinolysis; 1994 Apr; 5(2):233-8. PubMed ID: 8054455
[TBL] [Abstract][Full Text] [Related]
18. A novel fibrinogen variant--Liberec: dysfibrinogenaemia associated with gamma Tyr262Cys substitution.
Kotlín R; Sobotková A; Suttnar J; Salaj P; Walterová L; Riedel T; Reicheltová Z; Dyr JE
Eur J Haematol; 2008 Aug; 81(2):123-9. PubMed ID: 18485115
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen Bern I: substitution gamma 337 Asn-->Lys is responsible for defective fibrin monomer polymerization.
Steinmann C; Reber P; Jungo M; Lämmle B; Heinemann G; Wermuth B; Furlan M
Blood; 1993 Oct; 82(7):2104-8. PubMed ID: 8400260
[TBL] [Abstract][Full Text] [Related]
20. Characterization of fibrinogen Milano I: amino acid exchange gamma 330 Asp----Val impairs fibrin polymerization.
Reber P; Furlan M; Rupp C; Kehl M; Henschen A; Mannucci PM; Beck EA
Blood; 1986 Jun; 67(6):1751-6. PubMed ID: 3708159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]